Advertisement

Alibaba’s Lazada posts first monthly profit amid intense competition in Southeast Asia

  • Lazada’s CEO revealed in a town hall meeting on Tuesday that the firm achieved positive Ebitda, a measure of profitability, in July

Reading Time:2 minutes
Why you can trust SCMP
1
Alibaba Group Holding has invested around US$7.4 billion into Lazada since it acquired a controlling stake in the Singapore-based firm in 2016. Photo: Shutterstock
Ann Caoin Shanghai
Lazada, the Southeast Asian online shopping platform of Alibaba Group Holding, has achieved a monthly profit for the first time, according to an internal announcement.
In an announcement during the firm’s town hall meeting on Tuesday, Singapore-based Lazada was said to have recorded positive earnings before interest, taxes, depreciation and amortisation (Ebitda) – an alternate measure of profitability to net income – in July. Alibaba owns the South China Morning Post.
“This Ebitda-positive status proves the effectiveness of Lazada’s business strategy, and Lazada will continue to increase investment in the Southeast Asian market under a sustainable operating model,” company chief executive James Dong said in the meeting that was live-streamed to all of the firm’s employees. Dong also serves as chief executive at Daraz, Alibaba’s South Asian e-commerce platform.

That milestone was reached through various measures to improve efficiency, including artificial intelligence-enabled operations, online marketing, user incentives and optimised logistics services, according to a person familiar with the matter.

The person, who declined to be identified for having no authority to speak about the internal meeting, said Lazada plans other initiatives that would help ensure long-term success.

Lazada operates in Singapore, Indonesia, Malaysia, Thailand, Vietnam and the Philippines. Photo: Shutterstock
Lazada operates in Singapore, Indonesia, Malaysia, Thailand, Vietnam and the Philippines. Photo: Shutterstock

Lazada’s Ebitda-positive performance last month showed how Alibaba’s patient development strategy and capital injection, as well the Singapore-based company’s restructuring efforts and business strategy, are starting to pay off.

Advertisement